We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 8,962 results
  1. **nbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism

    Background

    Heart failure (HF) is characterized by a disorder of cardiomyocyte energy metabolism. **nbao Pill (XBW), a traditional Chinese medicine...

    Linjie Pan, Zhanchi Xu, ... Heqing Huang in Chinese Medicine
    Article Open access 11 June 2024
  2. Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation

    Background

    Cardiovascular diseases, including diabetic cardiomyopathy, are major causes of death in people with type 2 diabetes. Aldose reductase...

    Keshav Gopal, Qutuba G. Karwi, ... Gary D. Lopaschuk in Cardiovascular Diabetology
    Article Open access 28 March 2023
  3. Bawei Chenxiang Wan ameliorates right ventricular hypertrophy in rats with high altitude heart disease by SIRT3-HIF1α-PDK/PDH signaling pathway improving fatty acid and glucose metabolism

    Background

    Bawei Chenxiang Wan ( BCW ) is among the most effective and widely used therapies for coronary heart disease and angina pectoris in Tibet....

    Yiwei Han, Shadi Li, ... **aoying Zhang in BMC Complementary Medicine and Therapies
    Article Open access 15 May 2024
  4. Myocardial Metabolism in Heart Failure

    Purpose of Review

    Myocardial metabolism is intricately linked to cardiac function. Perturbations of cardiac energy metabolism result in an...

    Sher May Ng, Stefan Neubauer, Oliver J Rider in Current Heart Failure Reports
    Article Open access 17 February 2023
  5. Pharmacological Effects of Botanical Drugs on Myocardial Metabolism in Chronic Heart Failure

    Although there have been significant advances in the treatment of heart failure in recent years, chronic heart failure remains a leading cause of...

    Yu-xuan Hu, Sheng-lei Qiu, ... **ao-lei Lai in Chinese Journal of Integrative Medicine
    Article 26 September 2023
  6. Dual roles of myocardial mitochondrial AKT on diabetic cardiomyopathy and whole body metabolism

    Background

    The PI3K/AKT pathway transduces the majority of the metabolic actions of insulin. In addition to cytosolic targets, insulin-stimulated...

    Yu-Han Chen, Albert P. Ta, ... ** H. Wang in Cardiovascular Diabetology
    Article Open access 27 October 2023
  7. Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?

    Purpose of Review

    We review the clinical benefits of altering myocardial substrate metabolism in heart failure.

    Recent Findings

    Modulation of cardiac...

    Salva R. Yurista, Shi Chen, ... Christopher T. Nguyen in Current Heart Failure Reports
    Article 14 May 2022
  8. The abnormalities of free fatty acid metabolism in patients with hypertrophic cardiomyopathy, a single-center retrospective observational study

    Background

    Previous studies have shown the importance of energy deficiency and malfunctioning mitochondria in the pathophysiology of hypertrophic...

    Ke Zhang, Zhongyu Yuan, ... Yongqiang Lai in BMC Cardiovascular Disorders
    Article Open access 20 June 2024
  9. Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major

    Objectives

    This multicenter study assessed the extent of pancreatic fatty replacement and its correlation with demographics, iron overload, glucose...

    Antonella Meloni, Mario Nobile, ... Alessia Pepe in European Radiology
    Article Open access 28 April 2023
  10. Serum metabolism characteristics of patients with myocardial injury after noncardiac surgery explored by the untargeted metabolomics approach

    Background

    Myocardial injury after noncardiac surgery (MINS) is one of the most common complications associated with postoperative adverse...

    Yuanjia Zhang, Mengjia Kou, ... Xu Zhao in BMC Cardiovascular Disorders
    Article Open access 03 February 2024
  11. Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus

    Background

    Finerenone is a third-generation mineralocorticoid receptor antagonists, which has shown good cardiac function improvement in patients with...

    Tao **, **angrui Fu, ... Fengshuang An in Diabetology & Metabolic Syndrome
    Article Open access 29 April 2023
  12. Dynamic evolution and mechanism of myocardial glucose metabolism in different functional phenotypes of diabetic cardiomyopathy — a study based on 18 F-FDG microPET myocardial metabolic imaging

    Purpose

    To use 18 F-FDG microPET dynamic imaging to preliminarily identify the changes of myocardial glucose metabolism corresponding to different...

    **aoliang Shao, Yaqi Liu, ... Yuetao Wang in Diabetology & Metabolic Syndrome
    Article Open access 01 April 2023
  13. Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid β-oxidation to alleviate diabetic cardiomyopathy

    Background

    Diabetic cardiomyopathy (DCM) causes the myocardium to rely on fatty acid β-oxidation for energy. The accumulation of intracellular lipids...

    Meng-Yuan Jiang, Wan-Rong Man, ... Dong-Dong Sun in Military Medical Research
    Article Open access 11 December 2023
  14. Amino acid metabolism in health and disease

    Amino acids are the building blocks of protein synthesis. They are structural elements and energy sources of cells necessary for normal cell growth,...

    Zhe-Nan Ling, Yi-Fan Jiang, ... Jian Wu in Signal Transduction and Targeted Therapy
    Article Open access 13 September 2023
  15. Eicosapentaenoic Acid Preserves Mitochondrial Quality and Attenuates Cardiac Remodeling After Myocardial Infarction in Rats

    Eicosapentaenoic acid (EPA) reduces the risk of ischemic heart diseases and is a component of mitochondria. We herein investigated whether dietary...

    Miyuki Kobara, Tatsuya Shiraishi, ... Tetsuo Nakata in Journal of Cardiovascular Translational Research
    Article 27 February 2023
  16. Myocardial complications induced by hypothyroidism in rats: effects of metformin and alpha lipoic acid

    Hypothyroidism has adverse effects on heart metabolism and functions including reduced heart rate, cardiac output and cardiac contractility. The...

    Yasser A. Khadrawy, Eman N. Hosny, ... Hussein G. Sawie in Comparative Clinical Pathology
    Article 18 May 2024
  17. Silencing the FABP3 gene in insulin-secreting cells reduces fatty acid uptake and protects against lipotoxicity

    Background

    Long-term exposure of pancreatic islets to fatty acids (FAs), common in obesity, metabolic syndrome, and type 2 diabetes, leads to a...

    Ayman Hyder, Basma Sheta, ... Jürgen Schrezenmeir in Acta Diabetologica
    Article Open access 04 July 2024
  18. Protective role of arachidonic acid against diabetic myocardial ischemic injury: a translational study of pigs, rats, and humans

    Aim

    Patients with diabetes mellitus have poor prognosis after myocardial ischemic injury. However, the mechanism is unclear and there are no related...

    Yunhui Lv, Kai Li, ... Yongchun Cui in Cardiovascular Diabetology
    Article Open access 09 February 2024
  19. Management of Cardiovascular Diseases by Short-Chain Fatty Acid Postbiotics

    Purpose of Review

    Global health concerns persist in the realm of cardiovascular diseases (CVDs), necessitating innovative strategies for both...

    Seyed Sadeq Mousavi Ghahfarrokhi, Mohamadsadegh Mohamadzadeh, ... Ramin Khameneh Bagheri in Current Nutrition Reports
    Article 24 April 2024
Did you find what you were looking for? Share feedback.